Epigenomic	O
analysis	O
of	O
primary	O
human	O
T	O
cells	O
reveals	O
enhancers	O
associated	O
with	O
TH2	O
memory	O
cell	O
differentiation	O
and	O
asthma	S-DISEASE
susceptibility	O
.	O


A	O
characteristic	O
feature	O
of	O
asthma	S-DISEASE
is	O
the	O
aberrant	O
accumulation	O
,	O
differentiation	O
or	O
function	O
of	O
memory	O
CD4	O
(	O
+	O
)	O
T	O
cells	O
that	O
produce	O
type	O
2	O
cytokines	O
(	O
TH2	O
cells	O
)	O
.	O


By	O
mapping	O
genome	O
-	O
wide	O
histone	O
modification	O
profiles	O
for	O
subsets	O
of	O
T	O
cells	O
isolated	O
from	O
peripheral	O
blood	O
of	O
healthy	O
and	O
asthmatic	O
individuals	O
,	O
we	O
identified	O
enhancers	O
with	O
known	O
and	O
potential	O
roles	O
in	O
the	O
normal	O
differentiation	O
of	O
human	O
TH1	O
cells	O
and	O
TH2	O
cells	O
.	O


We	O
discovered	O
disease	O
-	O
specific	O
enhancers	O
in	O
T	O
cells	O
that	O
differ	O
between	O
healthy	O
and	O
asthmatic	O
individuals	O
.	O


Enhancers	O
that	O
gained	O
the	O
histone	O
H3	O
Lys4	O
dimethyl	O
(	O
H3K4me2	O
)	O
mark	O
during	O
TH2	O
cell	O
development	O
showed	O
the	O
highest	O
enrichment	O
for	O
asthma	S-DISEASE
-	O
associated	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
,	O
which	O
supported	O
a	O
pathogenic	O
role	O
for	O
TH2	O
cells	O
in	O
asthma	S-DISEASE
.	O


In	O
silico	O
analysis	O
of	O
cell	O
-	O
specific	O
enhancers	O
revealed	O
transcription	O
factors	O
,	O
microRNAs	O
and	O
genes	O
potentially	O
linked	O
to	O
human	O
TH2	O
cell	O
differentiation	O
.	O


Our	O
results	O
establish	O
the	O
feasibility	O
and	O
utility	O
of	O
enhancer	O
profiling	O
in	O
well	O
-	O
defined	O
populations	O
of	O
specialized	O
cell	O
types	O
involved	O
in	O
disease	O
pathogenesis	O
.	O
